Are Type and Screen Samples Routinely Necessary Before Laparoscopic Cholecystectomy?

Current surgical protocols often include routine blood testing before procedures, even when the likelihood of transfusion is low. While some studies suggest this is a standard precaution, others question its necessity. Prior research has shown that major complications requiring transfusion are rare in laparoscopic cholecystectomy (LC). However, the exact frequency of transfusion in this setting remains unclear. No prior work had resolved whether routine testing adds value in most cases. This uncertainty motivated a closer look at transfusion patterns in LC. Existing policy may not align with actual clinical need. The gap in understanding transfusion risk has led to calls for evidence-based revisions. This study aimed to address that gap by analyzing real-world transfusion data.

The study aimed to evaluate the need for routine blood testing before laparoscopic cholecystectomy. It sought to determine if such testing is justified based on transfusion rates in practice. The focus was on identifying whether transfusion is predictable from pre-operative status. The researchers wanted to assess if current policies are evidence-based. They analyzed data from a single tertiary center over a 30-month period. The goal was to inform potential changes in testing protocols. The study also aimed to identify factors associated with transfusion. It evaluated whether routine testing could be replaced with a selective approach.

The study used a retrospective case series design. It analyzed data from 1002 patients who underwent laparoscopic cholecystectomy. The time frame covered March 2014 to October 2016 at a tertiary center. Inclusion criteria included patients aged 16 or older and procedures converted to open surgery. Electronic records were used to extract transfusion and complication data. The researchers identified 12 patients who required transfusion during their admission. They compared transfused patients with those who did not need blood. The study also examined whether pre-operative testing was completed in all cases.

Out of 1002 patients, only 12 required transfusion (1.20%). No patient needed emergency transfusion or had major vascular injury. Ten of the transfused patients were admitted as emergencies. Pre-operative anemia was the main reason for transfusion in seven cases. Septic coagulopathy was the cause in two other cases. Only 106 patients (10.6%) lacked a valid pre-operative blood sample. Transfused patients were more likely to be emergency cases. The study found no intra-operative transfusions dependent on pre-operative blood testing.

The authors suggest that routine blood testing before laparoscopic cholecystectomy may not be necessary. They propose a selective approach based on pre-operative clinical status. Transfusion needs were predictable from patient characteristics. The findings indicate that current policies may be overly cautious. The study supports a shift toward evidence-based testing protocols. It highlights that transfusion rates are low in this surgical context. The authors recommend re-evaluating standard testing practices. They argue that selective testing could reduce healthcare costs without compromising safety.